Literature DB >> 27214887

On the Merits of Tetrapolar Impedance Spectroscopy for Monitoring Lithium Concentration Variations in Human Blood Plasma.

Loukas Constantinou, Iasonas F Triantis, Michelle Hickey, Panayiotis A Kyriacou.   

Abstract

Bipolar disorder is characterized as a manic-depressive psychiatric syndrome with life-threatening risks to the patient. Diagnosed individuals undergo long-term lithium therapy which has proven to be effective for mood stabilization. Maintaining blood lithium concentration levels within a narrow therapeutic window between 0.6 and 1.5 mM is vital for the patient as slightly elevated concentrations of the order of 0.1 mM can be toxic. This paper aims to evaluate the merits of tetrapolar electrical impedance spectroscopy as an alternative method in monitoring blood lithium levels. Measurements were performed using a custom-made tetrapolar probe in human blood plasma with lithium concentrations covering the therapeutic range. The results indicate a limit of detection less than 0.1 mM and a response time of less than 5 s. Prediction of lithium concentration levels using impedance values is in good agreement with conventional standard techniques to approximately 0.05 mM. This technique provides a basis for further development of instrumentation for point of care healthcare technologies.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27214887     DOI: 10.1109/TBME.2016.2570125

Source DB:  PubMed          Journal:  IEEE Trans Biomed Eng        ISSN: 0018-9294            Impact factor:   4.538


  2 in total

Review 1.  Advances in Therapeutic Monitoring of Lithium in the Management of Bipolar Disorder.

Authors:  Mahsa Sheikh; Meha Qassem; Iasonas F Triantis; Panicos A Kyriacou
Journal:  Sensors (Basel)       Date:  2022-01-19       Impact factor: 3.576

2.  Use of Transient Time Response as a Measure to Characterize Phononic Crystal Sensors.

Authors:  Simón Villa-Arango; David Betancur; Róbinson Torres; Panayiotis Kyriacou
Journal:  Sensors (Basel)       Date:  2018-10-25       Impact factor: 3.576

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.